Goji Berry 300 mg

by BIOVEA · capsule · 60 vegetarian capsules

  • On the market (NIH)
  • UPC 8 18423 02236 9
  • DSLD label 207380
  • Serving 2 vegetarian capsules
  • 30 servings

Goji Berry 300 mg by BIOVEA lists one ingredient: 600 mg of goji berry extract per serving of 2 vegetarian capsules. Its current label entered the NIH Dietary Supplement Label Database on November 21, 2019.

What is in Goji Berry 300 mg?

Each row as the label prints it, per serving of 2 vegetarian capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Goji Berry 300 mg: Supplement Facts rows against the market (DSLD label 207380, January 2026 release)
IngredientAmount% DVAmong products listing it
Goji berry extractGoji berry extract PlantPart: fruit Note: 4:1600 mg

Source: NIH ODS Dietary Supplement Label Database, label 207380 (entered November 21, 2019), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Daily Intake: Adults, take 2 capsules per day, as a dietary supplement.
Warnings
Warning: If you are pregnant or lactating, consult a healthcare professional before using this product.
Keep out of reach of children.
Do not use this product if the safety seal on the bottle is broken.
Allergens and what it does not contain
Gluten free Non-GMO
Storage
Store in a cool, dry place.

Source: label statements in DSLD label 207380.

What else is on the label?

Other ingredients: Rice Flour, Hydroxypropyl Methylcellulose, Vegetable Magnesium Stearate, Silicon Dioxide.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): GMP Compliant Gluten free VG Vegan.

How many labels does Goji Berry 300 mg have?

One label is on file, entered on November 21, 2019.

  1. Label 207380 (current) Entered November 21, 2019 · on the market · 60 vegetarian capsules · UPC 8 18423 02236 9

DSLD also links this label to: Goji Berry 600 mg (image difference, same product), Goji Berry 600 mg (image difference, same product), Goji Berry 600 mg (image difference, same product), Goji Berry 600 mg (image difference, same product), Goji Berry 600 mg (image difference, same product), Goji Berry 600 mg (image difference, same product), Goji Berry 600 mg (image difference, same product).

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names BIOVEA (distributor), Scottsdale, AZ. All BIOVEA products.

Where next?